Cart
sales@molnova.com
Camonagrel
CAS No. 105920-77-2
Camonagrel( —— )
Catalog No. M35990 CAS No. 105920-77-2
Camonagrel is a compound with inhibitory effects on Prostaglandin E2 (PGE2).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 922 | In Stock |
|
| 10MG | 1226 | In Stock |
|
| 25MG | 1853 | In Stock |
|
| 50MG | 2437 | In Stock |
|
| 100MG | 3283 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCamonagrel
-
NoteResearch use only, not for human use.
-
Brief DescriptionCamonagrel is a compound with inhibitory effects on Prostaglandin E2 (PGE2).
-
DescriptionCamonagrel is a compound that has inhibitory effects on Prostaglandin E2. Camonagrel is a potent thromboxane synthase inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
RecptorProstaglandin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number105920-77-2
-
Formula Weight272.3
-
Molecular FormulaC15H16N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(O)(=O)C1C=2C(=CC(OCCN3C=CN=C3)=CC2)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. M A Villalobos, et al. Effects of camonagrel, a selective inhibitor of platelet thromboxane synthase, on the platelet-subendothelium interaction. Pharmacology. 2003 Sep;69(1):44-50.?
molnova catalog
related products
-
MF-766
MF-766 is a highly potent, selective and orally active EP4 antagonist with a Ki of 0.23 nM. It behaves as a full antagonist with an IC50 of 1.4 nM (shifted to 1.8 nM in the presence of 10% HS) in the functional assay. It can be used for cancer and inflammation diseases research.
-
ASP7657
ASP7657 (ASP-7657) is a potent, selective, orally active prostaglandin EP4 receptor antagonist with Ki values of 6.02 nM and 2.21 nM for rat and human EP4 receptors, resepctively.
-
Secoxyloganin
Secoxyloganin possesses a hepato-protective effect. Secoxyloganin possesses antibacterial activity.
